{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:12:38Z","timestamp":1783523558314,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"DOI":"10.7759\/cureus.101994","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:17:23Z","timestamp":1769008643000},"source":"Crossref","is-referenced-by-count":2,"title":["From Anxiety, Depression to Major Neurocognitive Disorders: Exploring Their Association With the Risk Factors for Dementia"],"prefix":"10.7759","author":[{"given":"Ali A","family":"Sulais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Al Zamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Kaplan and Sadock's Synopsis of Psychiatry, 12th edition","author":"Sadock BJ","year":"2022","unstructured":"Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's Synopsis of Psychiatry, 12th edition. Lippincott Williams & Wilkins, Wolters Kluwer, Philadelphia (PA); 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Online; 2022. 10.1176\/appi.books.9780890425787"},{"key":"ref3","unstructured":"World Health Organization Dementia. (2025). Accessed. April 15, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"ref4","unstructured":"Alzheimer's disease international. dementia statistics. (2024). Accessed: August 10, 2024: https:\/\/www.alzint.org\/about\/dementia-facts-figures\/dementia-statistics\/."},{"key":"ref5","article-title":"Major Neurocognitive Disorder (Dementia). In","author":"Emmady PD","year":"202219202513","unstructured":"Emmady PD, Schoo C, Tadi P. Major Neurocognitive Disorder (Dementia). In. StatPearls, Treasure Island (FL): StatPearls Publishing; 202219202513."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2009.11.2\/hbrodaty","article-title":"Family caregivers of people with dementia","volume":"11","author":"Brodaty H","year":"2009","unstructured":"Brodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. 2009, 11:217-28. 10.31887\/DCNS.2009.11.2\/hbrodaty","journal-title":"Dialogues Clin Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2040622317712442","article-title":"Strategies for dementia prevention: latest evidence and implications","volume":"8","author":"Rakesh G","year":"2017","unstructured":"Rakesh G, Szabo ST, Alexopoulos GS, Zannas AS. Strategies for dementia prevention: latest evidence and implications. Ther Adv Chronic Dis. 2017, 8:121-36. 10.1177\/2040622317712442","journal-title":"Ther Adv Chronic Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000022163","article-title":"Is depression a risk factor for dementia or cognitive decline? A review","volume":"46","author":"Jorm AF","year":"2000","unstructured":"Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology. 2000, 46:219-27. 10.1159\/000022163","journal-title":"Gerontology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1961.tb07367.x","article-title":"Pseudo-dementia","volume":"37","author":"Kiloh LG","year":"1961","unstructured":"Kiloh LG. Pseudo-dementia. Acta Psychiatr Scand. 1961, 37:336-51. 10.1111\/j.1600-0447.1961.tb07367.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2018043","article-title":"Hans Selye (1907-1982): founder of the stress theory","volume":"59","author":"Tan SY","year":"2018","unstructured":"Tan SY, Yip A. Hans Selye (1907-1982): founder of the stress theory. Singapore Med J. 2018, 59:170-71. 10.11622\/smedj.2018043","journal-title":"Singapore Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.04.017","article-title":"Stress as risk factor for Alzheimer's disease","volume":"132","author":"Caruso A","year":"2018","unstructured":"Caruso A, Nicoletti F, Mango D, Saidi A, Orlando R, Scaccianoce S. Stress as risk factor for Alzheimer's disease. Pharmacol Res. 2018, 132:130-34. 10.1016\/j.phrs.2018.04.017","journal-title":"Pharmacol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.104323","article-title":"Hippocampus in health and disease: An overview","volume":"15","author":"Anand KS","year":"2012","unstructured":"Anand KS, Dhikav V. Hippocampus in health and disease: An overview. Ann Indian Acad Neurol. 2012, 15:239-46. 10.4103\/0972-2327.104323","journal-title":"Ann Indian Acad Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq203","article-title":"Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease","volume":"133","author":"Villain N","year":"2010","unstructured":"Villain N, Fouquet M, Baron JC, et al.. Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain. 2010, 133:3301-14. 10.1093\/brain\/awq203","journal-title":"Brain"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.10.045","article-title":"Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus","volume":"35","author":"Gianaros PJ","year":"2007","unstructured":"Gianaros PJ, Jennings JR, Sheu LK, Greer PJ, Kuller LH, Matthews KA. Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus. Neuroimage. 2007, 35:795-803. 10.1016\/j.neuroimage.2006.10.045","journal-title":"Neuroimage"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c150015","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman JP","year":"2016","unstructured":"Herman JP, McKlveen JM, Ghosal S, et al.. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016, 6:603-21. 10.1002\/cphy.c150015","journal-title":"Compr Physiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1590\/s1516-44462003000400010","article-title":"Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis","volume":"25","author":"Mello AF","year":"2003","unstructured":"Mello AF, Mello MF, Carpenter LL, Price LH. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Braz J Psychiatry. 2003, 25:231-38. 10.1590\/s1516-44462003000400010","journal-title":"Braz J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e31820ad12b","article-title":"Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research","volume":"73","author":"Stetler C","year":"2011","unstructured":"Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011, 73:114-26. 10.1097\/PSY.0b013e31820ad12b","journal-title":"Psychosom Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.04.008","article-title":"Stress, PTSD, and dementia","volume":"10","author":"Greenberg MS","year":"2014","unstructured":"Greenberg MS, Tanev K, Marin MF, Pitman RK. Stress, PTSD, and dementia. Alzheimers Dement. 2014, 10:S155-65. 10.1016\/j.jalz.2014.04.008","journal-title":"Alzheimers Dement"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.100002","article-title":"Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment","volume":"35","author":"Malykhin NV","year":"2010","unstructured":"Malykhin NV, Carter R, Seres P, Coupland NJ. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J Psychiatry Neurosci. 2010, 35:337-43. 10.1503\/jpn.100002","journal-title":"J Psychiatry Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000163456.22154.d2","article-title":"Hypercortisolemia and depression","volume":"67 Suppl 1","author":"Gillespie CF","year":"2005","unstructured":"Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med. 2005, 67 Suppl 1:S26-8. 10.1097\/01.psy.0000163456.22154.d2","journal-title":"Psychosom Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger JC","year":"2013","unstructured":"Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013, 246:199-229. 10.1016\/j.neuroscience.2013.04.060","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/149897","article-title":"Aging, depression and dementia: The inflammatory process","volume":"31","author":"Carrera-Gonz\u00e1lez MD","year":"2022","unstructured":"Carrera-Gonz\u00e1lez MD, Cant\u00f3n-Habas V, Rich-Ruiz M. Aging, depression and dementia: The inflammatory process. Adv Clin Exp Med. 2022, 31:469-73. 10.17219\/acem\/149897","journal-title":"Adv Clin Exp Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2018.12.004","article-title":"Depression and antidepressants as potential risk factors in dementia: a systematic review and meta-analysis of 18 longitudinal studies","volume":"20","author":"Chan JY","year":"2019","unstructured":"Chan JY, Yiu KK, Kwok TC, Wong SY, Tsoi KK. Depression and antidepressants as potential risk factors in dementia: a systematic review and meta-analysis of 18 longitudinal studies. J Am Med Dir Assoc. 2019, 20:279-286.e1. 10.1016\/j.jamda.2018.12.004","journal-title":"J Am Med Dir Assoc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.20230043","article-title":"Depression as a risk factor for dementia: a meta-analysis","volume":"36","author":"Fern\u00e1ndez Fern\u00e1ndez R","year":"2024","unstructured":"Fern\u00e1ndez Fern\u00e1ndez R, Mart\u00edn JI, Ant\u00f3n MA. Depression as a risk factor for dementia: a meta-analysis. J Neuropsychiatry Clin Neurosci. 2024, 36:101-9. 10.1176\/appi.neuropsych.20230043","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13153","article-title":"Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses","volume":"141","author":"Velosa J","year":"2020","unstructured":"Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo Cardoso T. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr Scand. 2020, 141:510-21. 10.1111\/acps.13153","journal-title":"Acta Psychiatr Scand"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.2362","article-title":"Association of lithium in drinking water with the incidence of dementia","volume":"74","author":"Kessing LV","year":"2017","unstructured":"Kessing LV, Gerds TA, Knudsen NN, et al.. Association of lithium in drinking water with the incidence of dementia. JAMA Psychiatry. 2017, 74:1005-10. 10.1001\/jamapsychiatry.2017.2362","journal-title":"JAMA Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.101931","article-title":"Affective disorders and risk of developing dementia: systematic review","volume":"202","author":"da Silva J","year":"2013","unstructured":"da Silva J, Gon\u00e7alves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry. 2013, 202:177-86. 10.1192\/bjp.bp.111.101931","journal-title":"Br J Psychiatry"},{"key":"ref28","unstructured":"Mental disorders. (2025). Accessed. June 8, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-disorders."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2018.10.014","article-title":"Anxiety and risk of dementia: Systematic review and meta-analysis of prospective cohort studies","volume":"119","author":"Santab\u00e1rbara J","year":"2019","unstructured":"Santab\u00e1rbara J, Lipnicki DM, Villagrasa B, Lobo E, Lopez-Anton R. Anxiety and risk of dementia: Systematic review and meta-analysis of prospective cohort studies. Maturitas. 2019, 119:14-20. 10.1016\/j.maturitas.2018.10.014","journal-title":"Maturitas"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.173","article-title":"Anxiety as a risk factor of Alzheimer's disease and vascular dementia","volume":"213","author":"Becker E","year":"2018","unstructured":"Becker E, Orellana Rios CL, Lahmann C, R\u00fccker G, Bauer J, Boeker M. Anxiety as a risk factor of Alzheimer's disease and vascular dementia. Br J Psychiatry. 2018, 213:654-60. 10.1192\/bjp.2018.173","journal-title":"Br J Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2016.05.015","article-title":"Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis","volume":"24","author":"Gulpers B","year":"2016","unstructured":"Gulpers B, Ramakers I, Hamel R, K\u00f6hler S, Oude Voshaar R, Verhey F.  Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry. 2016, 24:823-42. 10.1016\/j.jagp.2016.05.015","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref32","article-title":"The Clinical Roots of the Schizophrenia Concept: Translations of Seminal European Contributions on Schizophrenia","author":"Cutting J","year":"1987","unstructured":"Cutting J, Shepherd M. The Clinical Roots of the Schizophrenia Concept: Translations of Seminal European Contributions on Schizophrenia. Cambridge, Cambridge University Press; 1987."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S172933","article-title":"Schizophrenia and risk of dementia: a meta-analysis study","volume":"14","author":"Cai L","year":"2018","unstructured":"Cai L, Huang J. Schizophrenia and risk of dementia: a meta-analysis study. Neuropsychiatr Dis Treat. 2018, 14:2047-55. 10.2147\/NDT.S172933","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2147\/nedt.2006.2.4.531","article-title":"Cognitive deficits and functional outcome in schizophrenia","volume":"2","author":"Bowie CR","year":"2006","unstructured":"Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2006, 2:531-6. 10.2147\/nedt.2006.2.4.531","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2020.150","article-title":"Post-traumatic stress disorder as a risk factor for dementia: systematic review and meta-analysis","volume":"217","author":"G\u00fcnak MM","year":"2020","unstructured":"G\u00fcnak MM, Billings J, Carratu E, Marchant NL, Favarato G, Orgeta V. Post-traumatic stress disorder as a risk factor for dementia: systematic review and meta-analysis. Br J Psychiatry. 2020, 217:600-8. 10.1192\/bjp.2020.150","journal-title":"Br J Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2022.03.003","article-title":"Epidemiology of insomnia: prevalence, course, risk factors, and public health burden","volume":"17","author":"Morin CM","year":"2022","unstructured":"Morin CM, Jarrin DC. Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin. 2022, 17:173-91. 10.1016\/j.jsmc.2022.03.003","journal-title":"Sleep Med Clin"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsw032","article-title":"Sleep, cognitive impairment, and Alzheimer's disease: a systematic review and meta-analysis","volume":"40","author":"Bubu OM","year":"2017","unstructured":"Bubu OM, Brannick M, Mortimer J, et al.. Sleep, cognitive impairment, and Alzheimer's disease: a systematic review and meta-analysis. Sleep. 2017, 40:10.1093\/sleep\/zsw032","journal-title":"Sleep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321896","article-title":"Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis","volume":"91","author":"Xu W","year":"2020","unstructured":"Xu W, Tan CC, Zou JJ, Cao XP, Tan L. Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2020, 91:236-44. 10.1136\/jnnp-2019-321896","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2017.06.010","article-title":"Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis","volume":"40","author":"Shi L","year":"2018","unstructured":"Shi L, Chen SJ, Ma MY, et al.. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev. 2018, 40:4-16. 10.1016\/j.smrv.2017.06.010","journal-title":"Sleep Med Rev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040803","article-title":"Sleep disturbance as a potential modifiable risk factor for Alzheimer's disease","volume":"20","author":"Minakawa EN","year":"2019","unstructured":"Minakawa EN, Wada K, Nagai Y. Sleep disturbance as a potential modifiable risk factor for Alzheimer's disease. Int J Mol Sci. 2019, 20:10.3390\/ijms20040803","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2018.11.005","article-title":"Disrupted structural and functional brain networks in Alzheimer's disease","volume":"75","author":"Dai Z","year":"2019","unstructured":"Dai Z, Lin Q, Li T, et al.. Disrupted structural and functional brain networks in Alzheimer's disease. Neurobiol Aging. 2019, 75:71-82. 10.1016\/j.neurobiolaging.2018.11.005","journal-title":"Neurobiol Aging"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/801341","article-title":"Sleep loss as a factor to induce cellular and molecular inflammatory variations","volume":"2013","author":"Hurtado-Alvarado G","year":"2013","unstructured":"Hurtado-Alvarado G, Pav\u00f3n L, Castillo-Garc\u00eda SA, Hern\u00e1ndez ME, Dom\u00ednguez-Salazar E, Vel\u00e1zquez-Moctezuma J, G\u00f3mez-Gonz\u00e1lez B. Sleep loss as a factor to induce cellular and molecular inflammatory variations. Clin Dev Immunol. 2013, 2013:801341. 10.1155\/2013\/801341","journal-title":"Clin Dev Immunol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s11121-022-01385-1","article-title":"Is stress an overlooked risk factor for dementia? A systematic review from a lifespan developmental perspective","volume":"24","author":"Luo J","year":"2023","unstructured":"Luo J, Beam CR, Gatz M.  Is stress an overlooked risk factor for dementia? A systematic review from a lifespan developmental perspective. Prev Sci. 2023, 24:936-49. 10.1007\/s11121-022-01385-1","journal-title":"Prev Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2668","article-title":"Prevalence of adverse childhood experiences and their relationship to mental and physical illnesses in the Eastern Region of Saudi Arabia","volume":"12","author":"AlHemyari AH","year":"2022","unstructured":"AlHemyari AH, Al-Zamil NA, Shaikh AY, Al-Eidi DA, Al-Dahlan HW, Al-Shamekh SS. Prevalence of adverse childhood experiences and their relationship to mental and physical illnesses in the Eastern Region of Saudi Arabia. Brain Behav. 2022, 12:e2668. 10.1002\/brb3.2668","journal-title":"Brain Behav"},{"key":"ref45","unstructured":"A public health approach to adverse childhood experiences. US Department of Health and Human Services. (2024). Accessed. October 2, 2025: https:\/\/www.cdc.gov\/aces\/php\/public-health-strategy\/index.html."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.579899","article-title":"Drugs with anticholinergic properties: a current perspective on use and safety","volume":"10","author":"Gerretsen P","year":"2011","unstructured":"Gerretsen P, Pollock BG. Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opin Drug Saf. 2011, 10:751-65. 10.1517\/14740338.2011.579899","journal-title":"Expert Opin Drug Saf"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24536","article-title":"Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis","volume":"40","author":"Dmochowski RR","year":"2021","unstructured":"Dmochowski RR, Thai S, Iglay K, et al.. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis. Neurourol Urodyn. 2021, 40:28-37. 10.1002\/nau.24536","journal-title":"Neurourol Urodyn"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.04.031","article-title":"Anticholinergic drugs and the risk of dementia: a systematic review and meta-analysis","volume":"127","author":"Zheng YB","year":"2021","unstructured":"Zheng YB, Shi L, Zhu XM, et al.. Anticholinergic drugs and the risk of dementia: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021, 127:296-306. 10.1016\/j.neubiorev.2021.04.031","journal-title":"Neurosci Biobehav Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01883-8","article-title":"Anticholinergic burden and incident dementia: a Swedish nationwide case-control study","volume":"17","author":"Zhu N","year":"2025","unstructured":"Zhu N, Eriksdotter M, Liabeuf S, Tan EC, Johnell K, Garcia-Ptacek S, Xu H. Anticholinergic burden and incident dementia: a Swedish nationwide case-control study. Alzheimers Res Ther. 2025, 17:227. 10.1186\/s13195-025-01883-8","journal-title":"Alzheimers Res Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis","volume":"47","author":"Islam MM","year":"2016","unstructured":"Islam MM, Iqbal U, Walther B, et al.. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016, 47:181-91. 10.1159\/000454881","journal-title":"Neuroepidemiology"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1014796","article-title":"Is there really a link between benzodiazepine use and the risk of dementia?","volume":"14","author":"Billioti de Gage S","year":"2015","unstructured":"Billioti de Gage S, Pariente A, B\u00e9gaud B. Is there really a link between benzodiazepine use and the risk of dementia?. Expert Opin Drug Saf. 2015, 14:733-47. 10.1517\/14740338.2015.1014796","journal-title":"Expert Opin Drug Saf"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2019.15.1.9","article-title":"Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies","volume":"15","author":"He Q","year":"2019","unstructured":"He Q, Chen X, Wu T, Li L, Fei X. Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies. J Clin Neurol. 2019, 15:9-19. 10.3988\/jcn.2019.15.1.9","journal-title":"J Clin Neurol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127836","article-title":"Association between benzodiazepine use and dementia: a meta-analysis","volume":"10","author":"Zhong G","year":"2015","unstructured":"Zhong G, Wang Y, Zhang Y, Zhao Y. Association between benzodiazepine use and dementia: a meta-analysis. PLoS One. 2015, 10:e0127836. 10.1371\/journal.pone.0127836","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1600-y","article-title":"Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis","volume":"70","author":"D\u00e9sam\u00e9ricq G","year":"2014","unstructured":"D\u00e9sam\u00e9ricq G, Schurhoff F, Meary A, Sz\u00f6ke A, Macquin-Mavier I, Bachoud-L\u00e9vi AC, Maison P. Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis. Eur J Clin Pharmacol. 2014, 70:127-34. 10.1007\/s00228-013-1600-y","journal-title":"Eur J Clin Pharmacol"},{"key":"ref55","article-title":"Antipsychotic effects on cognition in schizophrenia: a meta-analysis of randomised controlled trials","author":"Guilera G","year":"1995","unstructured":"Guilera G, Pino O, G\u00f3mez-Benito J, et al.. Antipsychotic effects on cognition in schizophrenia: a meta-analysis of randomised controlled trials. Database of Abstracts of Reviews of Effects (DARE). Quality-assessed Reviews [Internet], York (UK): Centre for Reviews and Dissemination (UK); 1995-2009."},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.03.013","article-title":"High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction","volume":"30","author":"Kawai N","year":"2006","unstructured":"Kawai N, Yamakawa Y, Baba A, et al.. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction. Prog Neuropsychopharmacol Biol Psychiatry. 2006, 30:1009-14. 10.1016\/j.pnpbp.2006.03.013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/9781119870203.ffirs.pub2","article-title":"The Maudsley Guidelines in Psychiatry. 15th ed","author":"Taylor DM","year":"2025","unstructured":"Taylor DM, Barnes TRE, Young AH. The Maudsley Guidelines in Psychiatry. 15th ed. Wiley Blackwell, 2025. 10.1002\/9781119870203.ffirs.pub2"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003941","article-title":"Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study","volume":"19","author":"Chen S","year":"2022","unstructured":"Chen S, Underwood BR, Jones PB, Lewis JR, Cardinal RN. Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study. PLoS Med. 2022, 19:e1003941. 10.1371\/journal.pmed.1003941","journal-title":"PLoS Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1159\/000538846","article-title":"Lithium therapy's potential to lower dementia risk and the prevalence of Alzheimer's disease: a meta-analysis","volume":"87","author":"Lu Q","year":"2024","unstructured":"Lu Q, Lv H, Liu X, Zang L, Zhang Y, Meng Q. Lithium therapy's potential to lower dementia risk and the prevalence of Alzheimer's disease: a meta-analysis. Eur Neurol. 2024, 87:93-104. 10.1159\/000538846","journal-title":"Eur Neurol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12449","article-title":"Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations","volume":"18","author":"De-Paula VJ","year":"2016","unstructured":"De-Paula VJ, Gattaz WF, Forlenza OV. Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations. Bipolar Disord. 2016, 18:692-5. 10.1111\/bdi.12449","journal-title":"Bipolar Disord"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina S","year":"2015","unstructured":"Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015, 11:1164-78. 10.5114\/aoms.2015.56342","journal-title":"Arch Med Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1133816","article-title":"Anti-seizure medication exposure and the risk of dementia: A meta-analysis of observational studies","volume":"14","author":"Zhang L","year":"2023","unstructured":"Zhang L, Jiang HY, Liu WJ. Anti-seizure medication exposure and the risk of dementia: A meta-analysis of observational studies. Front Neurol. 2023, 14:1133816. 10.3389\/fneur.2023.1133816","journal-title":"Front Neurol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172270","article-title":"Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression","volume":"12","author":"Zhou C","year":"2017","unstructured":"Zhou C, Zhong J, Zou B, et al.. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS One. 2017, 12:e0172270. 10.1371\/journal.pone.0172270","journal-title":"PLoS One"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2009.03.009","article-title":"Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies","volume":"79","author":"Drzyzga \u0141R","year":"2009","unstructured":"Drzyzga \u0141R, Marcinowska A, Obuchowicz E. Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies. Brain Res Bull. 2009, 79:248-57. 10.1016\/j.brainresbull.2009.03.009","journal-title":"Brain Res Bull"},{"key":"ref65","doi-asserted-by":"crossref","DOI":"10.1139\/jpn.0422","article-title":"Implications of adult hippocampal neurogenesis in antidepressant action","volume":"29","author":"Malberg JE","year":"2004","unstructured":"Malberg JE. Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci. 2004, 29:196-205.","journal-title":"J Psychiatry Neurosci"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32834ace0f","article-title":"Do continued antidepressants protect against dementia in patients with severe depressive disorder?","volume":"26","author":"Kessing LV","year":"2011","unstructured":"Kessing LV, Forman JL, Andersen PK. Do continued antidepressants protect against dementia in patients with severe depressive disorder?. Int Clin Psychopharmacol. 2011, 26:316-22. 10.1097\/YIC.0b013e32834ace0f","journal-title":"Int Clin Psychopharmacol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0847-z","article-title":"Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort","volume":"15","author":"Carri\u00e8re I","year":"2017","unstructured":"Carri\u00e8re I, Norton J, Farr\u00e9 A, et al.. Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort. BMC Med. 2017, 15:81. 10.1186\/s12916-017-0847-z","journal-title":"BMC Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/da.22584","article-title":"The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis","volume":"34","author":"Moraros J","year":"2017","unstructured":"Moraros J, Nwankwo C, Patten SB, Mousseau DD. The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. Depress Anxiety. 2017, 34:217-26. 10.1002\/da.22584","journal-title":"Depress Anxiety"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5315098","article-title":"Increased risk of dementia in patients with antidepressants: a meta-analysis of observational studies","volume":"2018","author":"Wang YC","year":"2018","unstructured":"Wang YC, Tai PA, Poly TN, Islam MM, Yang HC, Wu CC, Li YJ. Increased risk of dementia in patients with antidepressants: a meta-analysis of observational studies. Behav Neurol. 2018, 2018:5315098. 10.1155\/2018\/5315098","journal-title":"Behav Neurol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glx226","article-title":"Antidepressant use and cognitive outcomes in very old women","volume":"73","author":"Leng Y","year":"2018","unstructured":"Leng Y, Diem SJ, Stone KL, Yaffe K. Antidepressant use and cognitive outcomes in very old women. J Gerontol A Biol Sci Med Sci. 2018, 73:1390-95. 10.1093\/gerona\/glx226","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/449152-from-anxiety-depression-to-major-neurocognitive-disorders-exploring-their-association-with-the-risk-factors-for-dementia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:17:25Z","timestamp":1769008645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/449152-from-anxiety-depression-to-major-neurocognitive-disorders-exploring-their-association-with-the-risk-factors-for-dementia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":70,"URL":"https:\/\/doi.org\/10.7759\/cureus.101994","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}